Mon, Dec 29, 2014, 5:07 AM EST - U.S. Markets open in 4 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • supermba_2000 supermba_2000 Nov 28, 2012 11:17 PM Flag

    Avanir Pharmaceuticals Stock Rating Reaffirmed by Canaccord Genuity (AVNR)

    "Avanir Pharmaceuticals Stock Rating Reaffirmed by Canaccord Genuity (AVNR)
    Posted by LUSA Staff on Nov 28th, 2012

    Avanir Pharmaceuticals (NASDAQ: AVNR)‘s stock had its “buy” rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Wednesday.

    Separately, analysts at Cowen initiated coverage on shares of Avanir Pharmaceuticals in a research note to investors on Monday, October 1st. They set an “outperform” rating on the stock.

    Avanir Pharmaceuticals traded up 5.08% on Wednesday, hitting $2.795. Avanir Pharmaceuticals has a 1-year low of $1.77 and a 1-year high of $4.05. The company’s market cap is $380.6 million."

16.92+0.01(+0.06%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Belmond Ltd.
NYSEFri, Dec 26, 2014 4:01 PM EST
Novo Nordisk A/S
NYSEFri, Dec 26, 2014 4:03 PM EST